Goodair Nosebuds develops a technology designed to relieve nasal congestion without the use of drugs.
Goodair Nosebuds has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Goodair Nosebuds's investors include Callaghan Innovation, WNT Ventures, Alt Ventures.
Goodair Nosebuds is headquartered in Auckland, New Zealand.
Goodair Nosebuds develops a technology designed to relieve nasal congestion without the use of drugs.
Goodair Nosebuds is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Goodair Nosebuds — Funding & Investors." VCBacked, December 11, 2023, https://www.vcbacked.co/company/goodair-nosebuds. Accessed October 21, 2026.
VCBacked. (2023). Goodair Nosebuds — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/goodair-nosebuds
{{cite web |title=Goodair Nosebuds — Funding & Investors |url=https://www.vcbacked.co/company/goodair-nosebuds |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated